Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
BERKELEY, Calif. and MAINZ, Germany, March 03, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
DNA
Connect Biopharma to Present at Two Upcoming Investor Conferences
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a...
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
- Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU -- 82% of...
4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial...
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
-- On track to report initial data from Phase 1/2 clinical trial of PM359 for p47phox CGD in 2025 --...
LA FIRE VICTIMS CAN RELEASE SOME OF THE STRESS: NUCALM AND TONY ROBBINS JOIN FORCES TO GIVE BACK
NuCalm Donates One-Year Membership to their Mobile App to Help Families Heal from the Trauma of Loss and Displacement WILMINGTON,...
Ubie and Nucleus Genomics Partner to Enhance Access to Genetic Testing and Drive Early Screening for Improved Health Outcomes
Genetic testing can be critical to ensuring the early diagnosis and proper treatment of serious disease for patients of all...
Rakovina Therapeutics and Variational AI Strengthen Partnership
Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered CollaborationsVANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE...
IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to...
Korro to Present at the TD Cowen 45th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on...
Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer
Accomplished regulatory affairs veteran to lead company’s global regulatory strategy and drug product developmentNEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE)...
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results
Ginkgo provides update on its restructuring process including significant improvement in cash flow in the fourth quarter, completion of site...
Discovery Life Sciences Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con in San Diego
Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies HUNTSVILLE, Ala., Feb. 25, 2025 /PRNewswire/ -- Discovery Life Sciences...
Nucleus Genomics Hires Romain Daguet, Award-Winning Founder and Engineer
Investment in engineering team signals Nucleus' commitment to innovation and putting comprehensive health data in the hands of users NEW...
Ultima Genomics expands global access to high-quality, low-cost DNA sequencing on the UG 100™ sequencing platform through partnerships with multiple premier genomic services providers
FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded...
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25...
StaffDNA® is Awarded 13 Patents by the U.S. Patent and Trademark Office
PLANO, Texas, Feb. 24, 2025 /PRNewswire/ -- StaffDNA, the innovative digital marketplace that improves the healthcare hiring ecosystem, has recently...
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a...
Ultima Genomics increases output by over 50% and lowers sequencing costs by a further 20% with the introduction of UG 100 Solaris™
Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now...
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sleep apnea...